La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Afya Gestion

Gestion contrôle des critères 2/4

Le PDG Afya's est Virgilio Deloy Gibbon, nommé en Jul2019, a un mandat de 5.08 ans. détient directement 0.44% des actions de la société, d'une valeur de $ 7.36M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 5.1 ans et 4 ans.

Informations clés

Virgilio Deloy Gibbon

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDG	n/a
Durée du mandat du directeur général	5.1yrs
Propriété du PDG	0.4%
Durée moyenne d'occupation des postes de direction	5.1yrs
Durée moyenne du mandat des membres du conseil d'administration	4yrs

Mises à jour récentes de la gestion

Recent updates

Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Aug 15

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Jul 17

Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jun 20

What Type Of Returns Would Afya's(NASDAQ:AFYA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 24

Afya BOD approves share buyback program

Dec 23

Afya reports Q3 results

Dec 03

Is Afya Limited's (NASDAQ:AFYA) 10% ROE Strong Compared To Its Industry?

Dec 03

PDG

Virgilio Deloy Gibbon (48 yo)

5.1yrs

Titularisation

Mr. Virgilio Deloy Capobianco Gibbon is Chief Executive Officer of Afya Limited since July 2019. He has been the Chief Executive Officer of Afya Brazil since August 2016. Prior to joining us, he was Chief...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Virgilio Deloy Gibbon	Chief Executive Officer	5.1yrs	pas de données	0.43% R$ 7.1m
Luis Andre Blanco	Chief Financial Officer	4.3yrs	pas de données	0.047% R$ 778.3k
Renata Couto	Investor Relations Executive Manager	no data	pas de données	pas de données
Julio Eduardo de Angeli	Vice President of Continuing Education & Innovation	5.1yrs	pas de données	pas de données

5.1yrs

Durée moyenne de l'emploi

51yo

Âge moyen

Gestion expérimentée: L'équipe de direction de AFYA est chevronnée et expérimentée (ancienneté moyenne 5.1 ans).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Kay Krafft	Co-Chairman	3yrs	pas de données	pas de données
Maria Azevedo	Director	2.3yrs	pas de données	pas de données
Vanessa Lopes	Independent Director	5.1yrs	pas de données	0.0015% R$ 24.3k
Nicolau Esteves	Co-Chairman	5.1yrs	pas de données	18.67% R$ 311.1m
Renato Esteves	Director	5.1yrs	pas de données	2.82% R$ 47.0m
Miguel Filisbino De Paula	Independent Director	4yrs	pas de données	pas de données
Joao Paulo De Faria	Independent Director	4yrs	pas de données	pas de données
Christina Krebs	Director	2.3yrs	pas de données	pas de données
Benedikt Dalkmann	Director	2.3yrs	pas de données	pas de données
Marcelo Suhara	Independent Director	no data	pas de données	pas de données

4.0yrs

Durée moyenne de l'emploi

48.5yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de AFYA sont considérés comme expérimentés (ancienneté moyenne 4 ans).

Afya Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

Afya Limited Announces the Resignation of Shobhna Mohn as a Member of the Board of Directors

Afya Limited, Annual General Meeting, Jun 05, 2024

Afya Limited, Annual General Meeting, Jun 15, 2023

Afya Announces Changes to Its Board of Directors

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Second quarter 2024 earnings: EPS exceeds analyst expectations

Afya Limited Updates Financial Guidance for the Year 2024

Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Afya Limited to Report Q2, 2024 Results on Aug 14, 2024

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Limited Announces the Resignation of Shobhna Mohn as a Member of the Board of Directors

Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Afya's Results Are Improving And The Market Is Undervaluing It

Afya Limited, Annual General Meeting, Jun 05, 2024

Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

Afya Limited Reports Unaudited Consolidated Write-Off Results for the First Quarter Ended March 31, 2024

Afya Limited Reports Unaudited Consolidated Write-Off Results for the First Quarter Ended March 31, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

AFYA: Mr Market Is Mistaken

Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Is Performing Well And Is A Buy

Full year 2023 earnings: EPS misses analyst expectations

Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Afya Limited Provides Earnings Guidance for the FY2024

Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

Afya Limited to Report Q4, 2023 Results on Mar 14, 2024

These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Consensus EPS estimates fall by 14%

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Consensus EPS estimates increase by 11%

Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

Afya Limited to Report Q3, 2023 Results on Nov 13, 2023

What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Afya Limited to Report Q2, 2023 Results on Aug 28, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Afya Limited to Report Q1, 2023 Results on May 24, 2023

Afya Limited, Annual General Meeting, Jun 15, 2023

Investor sentiment improves as stock rises 19%

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates increase by 12%

Afya Announces Changes to Its Board of Directors

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Investor sentiment improved over the past week

Afya Limited to Report Q3, 2022 Results on Nov 21, 2022

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Afya GAAP EPS of R$1.12, revenue of R$598.16M; reaffirms FY22 guidance

Investor sentiment improved over the past week

White Brook Capital - AFYA Ltd: Cheap Stock, Good Business, Inherent Growth

Afya Limited to Report Q2, 2022 Results on Aug 22, 2022

Consensus forecasts updated

First quarter 2022 earnings: EPS exceeds analyst expectations

Investor sentiment deteriorated over the past week

Erste Wv GÜTersloh Gmbh signed a basic agreement to acquire additional 2.4% stake in Afya Limited (NasdaqGS:AFYA) from Nicolau Carvalho Esteves Rosângela de Oliveira Tavares Esteves and NRE Capital Ventures Ltd.

Less than half of directors are independent

Afya Limited Announces Changes to its Board of Directors

Afya Limited to Report Q1, 2022 Results on May 23, 2022

Afya Limited, Annual General Meeting, Apr 29, 2022

Afya: Margin And Organic Growth Struggles Remain Top Of Mind

Full year 2021 earnings: EPS misses analyst expectations

Investor sentiment improved over the past week

Consensus forecasts updated

Afya Limited to Report Q4, 2021 Results on Mar 31, 2022

Investor sentiment improved over the past week

Afya On A Grey Price Area

Consensus forecasts updated

Third quarter 2021 earnings: Revenues exceed analyst expectations

Afya: The Longer-Term Growth Story Remains Intact

Afya Limited Provides Earnings Guidance for the Second Half of 2021